| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | microtubule-based process | CFAP47 KIFBP XRN2 TRAF3IP1 WEE1 TUBA3D TUBA1C NUMA1 PEX1 DAG1 TUBA3E QRICH2 TUBA3C ENO4 FSIP2 TUBA1B CCDC13 CFAP52 TUBA1A INSC MACF1 CEP295 RPGR CFAP69 BBS12 HYDIN | 5.91e-08 | 1058 | 152 | 26 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CFAP47 KIFBP TRAF3IP1 WEE1 TUBA3D TUBA1C NUMA1 DAG1 TUBA3E TUBA3C FSIP2 TUBA1B CCDC13 TUBA1A INSC CEP295 CFAP69 HYDIN | 6.22e-06 | 720 | 152 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | cilium organization | CFAP47 RPGRIP1 TRAF3IP1 USP9X BBS10 ENO4 FSIP2 CCDC13 WDR90 RPGR CFAP69 BBS12 HYDIN | 5.33e-05 | 476 | 152 | 13 | GO:0044782 |
| GeneOntologyCellularComponent | axonemal central pair projection | 5.82e-05 | 2 | 160 | 2 | GO:1990718 | |
| GeneOntologyCellularComponent | primary lysosome | 2.36e-04 | 160 | 160 | 7 | GO:0005766 | |
| GeneOntologyCellularComponent | azurophil granule | 2.36e-04 | 160 | 160 | 7 | GO:0042582 | |
| GeneOntologyCellularComponent | cilium | CFAP47 RPGRIP1 TRAF3IP1 USP9X PPEF2 QRICH2 BBS10 ENO4 FSIP2 CFAP52 TUBA1A SQSTM1 PRKAR2B RPGR CFAP69 BBS12 HYDIN | 5.38e-04 | 898 | 160 | 17 | GO:0005929 |
| GeneOntologyCellularComponent | azurophil granule lumen | 6.75e-04 | 91 | 160 | 5 | GO:0035578 | |
| GeneOntologyCellularComponent | axonemal central apparatus | 8.56e-04 | 6 | 160 | 2 | GO:1990716 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 8.56e-04 | 6 | 160 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 8.61e-04 | 96 | 160 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 9.02e-04 | 97 | 160 | 5 | GO:0071013 | |
| GeneOntologyCellularComponent | photoreceptor distal connecting cilium | 1.19e-03 | 7 | 160 | 2 | GO:0120206 | |
| GeneOntologyCellularComponent | INO80-type complex | 1.25e-03 | 28 | 160 | 3 | GO:0097346 | |
| GeneOntologyCellularComponent | sperm flagellum | 1.33e-03 | 214 | 160 | 7 | GO:0036126 | |
| GeneOntologyCellularComponent | sperm midpiece | 1.47e-03 | 64 | 160 | 4 | GO:0097225 | |
| Domain | Alpha_tubulin | 4.10e-09 | 9 | 152 | 5 | IPR002452 | |
| Domain | - | 4.70e-07 | 20 | 152 | 5 | 3.30.1330.20 | |
| Domain | - | 6.12e-07 | 21 | 152 | 5 | 1.10.287.600 | |
| Domain | Tubulin_C | 7.87e-07 | 22 | 152 | 5 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 7.87e-07 | 22 | 152 | 5 | IPR018316 | |
| Domain | - | 7.87e-07 | 22 | 152 | 5 | 3.40.50.1440 | |
| Domain | Tubulin_C | 7.87e-07 | 22 | 152 | 5 | SM00865 | |
| Domain | Tub_FtsZ_C | 9.99e-07 | 23 | 152 | 5 | IPR008280 | |
| Domain | Tubulin_C | 9.99e-07 | 23 | 152 | 5 | IPR023123 | |
| Domain | TUBULIN | 9.99e-07 | 23 | 152 | 5 | PS00227 | |
| Domain | Tubulin | 9.99e-07 | 23 | 152 | 5 | IPR000217 | |
| Domain | Tubulin | 9.99e-07 | 23 | 152 | 5 | SM00864 | |
| Domain | Tubulin_CS | 9.99e-07 | 23 | 152 | 5 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 1.25e-06 | 24 | 152 | 5 | IPR003008 | |
| Domain | Tubulin | 1.25e-06 | 24 | 152 | 5 | PF00091 | |
| Domain | DUF1220 | 1.33e-06 | 11 | 152 | 4 | PF06758 | |
| Domain | NBPF_dom | 1.33e-06 | 11 | 152 | 4 | IPR010630 | |
| Domain | NBPF | 1.33e-06 | 11 | 152 | 4 | PS51316 | |
| Domain | SPIN/Ssty | 5.22e-06 | 5 | 152 | 3 | IPR003671 | |
| Domain | Spin-Ssty | 5.22e-06 | 5 | 152 | 3 | PF02513 | |
| Domain | DUF1220 | 4.28e-05 | 9 | 152 | 3 | SM01148 | |
| Domain | SPIN-2 | 6.58e-05 | 2 | 152 | 2 | IPR029564 | |
| Domain | GROEL-like_equatorial | 1.80e-04 | 14 | 152 | 3 | IPR027413 | |
| Domain | - | 1.80e-04 | 14 | 152 | 3 | 1.10.560.10 | |
| Domain | HnRNPA1 | 1.96e-04 | 3 | 152 | 2 | IPR021662 | |
| Domain | F_ACTIN_CAPPING_A_1 | 1.96e-04 | 3 | 152 | 2 | PS00748 | |
| Domain | F_ACTIN_CAPPING_A_2 | 1.96e-04 | 3 | 152 | 2 | PS00749 | |
| Domain | F-actin_cap_A | 1.96e-04 | 3 | 152 | 2 | PF01267 | |
| Domain | CapZ_alpha | 1.96e-04 | 3 | 152 | 2 | IPR002189 | |
| Domain | F-actin_cap_asu_CS | 1.96e-04 | 3 | 152 | 2 | IPR017865 | |
| Domain | HnRNPA1 | 1.96e-04 | 3 | 152 | 2 | PF11627 | |
| Domain | GroEL-like_apical_dom | 2.24e-04 | 15 | 152 | 3 | IPR027409 | |
| Domain | Cpn60/TCP-1 | 2.24e-04 | 15 | 152 | 3 | IPR002423 | |
| Domain | Cpn60_TCP1 | 2.24e-04 | 15 | 152 | 3 | PF00118 | |
| Domain | - | 2.24e-04 | 15 | 152 | 3 | 3.50.7.10 | |
| Domain | Tyr_kinase_non-rcpt_Jak/Tyk2 | 3.91e-04 | 4 | 152 | 2 | IPR016251 | |
| Domain | ABC_membrane | 9.43e-04 | 24 | 152 | 3 | PF00664 | |
| Domain | Ribosomal_S6_kinase_II | 9.66e-04 | 6 | 152 | 2 | IPR016239 | |
| Domain | ABC_TM1F | 1.49e-03 | 28 | 152 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 1.49e-03 | 28 | 152 | 3 | IPR011527 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | TUBA3D TUBA1C CAPZA1 CAPZA2 TUBA3E TUBA3C TUBA1B TUBA1A HSPA1L | 6.99e-10 | 57 | 114 | 9 | M27251 |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.09e-09 | 26 | 114 | 7 | M9648 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 2.82e-09 | 17 | 114 | 6 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 4.20e-09 | 18 | 114 | 6 | M47753 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 4.88e-09 | 49 | 114 | 8 | M891 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.10e-09 | 19 | 114 | 6 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.10e-09 | 19 | 114 | 6 | M47813 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 6.74e-09 | 33 | 114 | 7 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 8.66e-09 | 20 | 114 | 6 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 8.66e-09 | 20 | 114 | 6 | M47911 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 9.34e-09 | 53 | 114 | 8 | M27651 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.20e-08 | 21 | 114 | 6 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.20e-08 | 21 | 114 | 6 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.64e-08 | 22 | 114 | 6 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 2.21e-08 | 23 | 114 | 6 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 2.21e-08 | 23 | 114 | 6 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 2.21e-08 | 23 | 114 | 6 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 2.93e-08 | 24 | 114 | 6 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.93e-08 | 24 | 114 | 6 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.83e-08 | 25 | 114 | 6 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.83e-08 | 25 | 114 | 6 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.94e-08 | 26 | 114 | 6 | M47672 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | TUBA3D RPS6KA2 RPS6KA3 TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A PRKAR2B | 6.44e-08 | 94 | 114 | 9 | M2843 |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 7.98e-08 | 28 | 114 | 6 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.00e-07 | 29 | 114 | 6 | M27948 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.62e-07 | 51 | 114 | 7 | M26972 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.87e-07 | 32 | 114 | 6 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.87e-07 | 32 | 114 | 6 | M27491 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 2.27e-07 | 33 | 114 | 6 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.28e-07 | 35 | 114 | 6 | M47774 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 5.48e-07 | 38 | 114 | 6 | M14981 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 6.38e-07 | 90 | 114 | 8 | M29841 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | TRAF3IP1 TUBA3D TUBA1C TUBA3E CCT2 TUBA3C BBS10 TUBA1B TUBA1A PRKAR2B BBS12 | 6.73e-07 | 201 | 114 | 11 | M27472 |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 9.67e-07 | 95 | 114 | 8 | M6729 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | WEE1 TUBA3D TUBA1C CAPZA1 CAPZA2 TUBA3E TUBA3C TUBA1B TUBA1A PRKAR2B | 1.15e-06 | 170 | 114 | 10 | M941 |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.17e-06 | 43 | 114 | 6 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 1.17e-06 | 43 | 114 | 6 | M47773 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.23e-06 | 98 | 114 | 8 | M776 | |
| Pathway | REACTOME_AGGREPHAGY | 1.35e-06 | 44 | 114 | 6 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.35e-06 | 44 | 114 | 6 | M27934 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.54e-06 | 45 | 114 | 6 | M47670 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.63e-06 | 71 | 114 | 7 | M39690 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.66e-06 | 102 | 114 | 8 | M27648 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.76e-06 | 46 | 114 | 6 | M27828 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.79e-06 | 72 | 114 | 7 | M26954 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.59e-06 | 76 | 114 | 7 | M48037 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 3.37e-06 | 79 | 114 | 7 | M27743 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 3.68e-06 | 52 | 114 | 6 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 4.61e-06 | 54 | 114 | 6 | M27482 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | TUBA3D TUBA1C CAPZA1 CAPZA2 TUBA3E TUBA3C PREB TUBA1B TUBA1A | 4.76e-06 | 156 | 114 | 9 | M27097 |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 5.14e-06 | 55 | 114 | 6 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 5.72e-06 | 56 | 114 | 6 | M2333 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 6.02e-06 | 121 | 114 | 8 | M872 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | MYO6 TUBA3D RPS6KA2 RPS6KA3 TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A PRKAR2B | 6.21e-06 | 205 | 114 | 10 | M752 |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | MLEC RPN1 TUBA3D TUBA1C CAPZA1 CAPZA2 TUBA3E TUBA3C PREB TUBA1B GLB1 TUBA1A | 6.98e-06 | 307 | 114 | 12 | M894 |
| Pathway | KEGG_GAP_JUNCTION | 8.07e-06 | 90 | 114 | 7 | M4013 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 8.12e-06 | 126 | 114 | 8 | M705 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 8.90e-06 | 17 | 114 | 4 | MM14731 | |
| Pathway | REACTOME_KINESINS | 9.47e-06 | 61 | 114 | 6 | M977 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | MYO6 ACHE TUBA3D RPS6KA2 RPS6KA3 TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A PRKAR2B | 1.17e-05 | 270 | 114 | 11 | M15514 |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 1.28e-05 | 134 | 114 | 8 | M27751 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | TUBA3D TUBA1C CAPZA1 CAPZA2 TUBA3E TUBA3C PREB TUBA1B TUBA1A | 2.05e-05 | 187 | 114 | 9 | M961 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.67e-05 | 44 | 114 | 5 | MM14606 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.68e-05 | 73 | 114 | 6 | MM15672 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | TRAF3IP1 TUBA3D TUBA1C TUBA3E CCT2 TUBA3C BBS10 TUBA1B TUBA1A PRKAR2B BBS12 | 2.83e-05 | 297 | 114 | 11 | M27050 |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 3.04e-05 | 151 | 114 | 8 | M550 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 3.38e-05 | 76 | 114 | 6 | M27215 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | WEE1 TUBA3D TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A FKBPL PRKAR2B | 3.49e-05 | 200 | 114 | 9 | M864 |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.11e-05 | 48 | 114 | 5 | MM15353 | |
| Pathway | REACTOME_AUTOPHAGY | 4.20e-05 | 158 | 114 | 8 | M27935 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 6.08e-05 | 52 | 114 | 5 | MM15211 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 6.17e-05 | 27 | 114 | 4 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 6.17e-05 | 27 | 114 | 4 | MM15674 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 8.24e-05 | 29 | 114 | 4 | MM15219 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | MYO6 ACHE TUBA3D RPS6KA2 RPS6KA3 TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A IL1RAPL2 PRKAR2B | 1.21e-04 | 411 | 114 | 12 | M735 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.22e-04 | 32 | 114 | 4 | MM14730 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.39e-04 | 140 | 114 | 7 | M27550 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.58e-04 | 100 | 114 | 6 | M27650 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.91e-04 | 66 | 114 | 5 | MM17074 | |
| Pathway | REACTOME_AGGREPHAGY | 1.96e-04 | 36 | 114 | 4 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 2.18e-04 | 37 | 114 | 4 | MM15102 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 2.40e-04 | 203 | 114 | 8 | M27654 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 2.49e-04 | 204 | 114 | 8 | M4217 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 3.07e-04 | 113 | 114 | 6 | M27471 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 3.07e-04 | 73 | 114 | 5 | MM15491 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 5.31e-04 | 20 | 114 | 3 | MM1383 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 5.73e-04 | 127 | 114 | 6 | M27181 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 6.38e-04 | 5 | 114 | 2 | MM15108 | |
| Pathway | REACTOME_MACROAUTOPHAGY | 6.48e-04 | 130 | 114 | 6 | MM14627 | |
| Pathway | WP_CILIOPATHIES | 7.32e-04 | 184 | 114 | 7 | M39880 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.06e-04 | 90 | 114 | 5 | M631 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 8.06e-04 | 90 | 114 | 5 | MM14979 | |
| Pathway | REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM | 8.11e-04 | 23 | 114 | 3 | M27481 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 8.86e-04 | 138 | 114 | 6 | M29805 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING | 9.52e-04 | 6 | 114 | 2 | M47936 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 9.81e-04 | 94 | 114 | 5 | MM14515 | |
| Pathway | REACTOME_KINESINS | 1.15e-03 | 57 | 114 | 4 | MM15714 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 1.17e-03 | 26 | 114 | 3 | M27750 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.26e-03 | 261 | 114 | 8 | M42565 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.26e-03 | 261 | 114 | 8 | MM15676 | |
| Pubmed | 3.78e-14 | 21 | 163 | 8 | 16079250 | ||
| Pubmed | 8.02e-13 | 9 | 163 | 6 | 21167302 | ||
| Pubmed | COL6A3 NBPF12 ERCC6 TRIO MYO6 RPN1 CAPZA1 TUBA3E HNRNPA1 TUBA3C NBPF1 TUBA1B NBPF15 TUBA1A NBPF9 NBPF10 NBPF14 HSPA1L | 4.41e-11 | 513 | 163 | 18 | 25798074 | |
| Pubmed | 2.49e-10 | 19 | 163 | 6 | 15698476 | ||
| Pubmed | 2.49e-10 | 19 | 163 | 6 | 15691386 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 5.26e-10 | 10 | 163 | 5 | 22973535 | |
| Pubmed | RPN1 TUBA1C TUBA3E CCT2 HNRNPA1L2 HNRNPA1 TUBA1B TUBA1A TPI1 | 6.61e-10 | 94 | 163 | 9 | 36584595 | |
| Pubmed | 6.77e-10 | 22 | 163 | 6 | 28117675 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | MYO6 RPN1 TUBA1C CAPZA1 TUBA3E CCT2 HNRNPA1L2 TUBA3C TUBA1B GLB1 TUBA1A HSPA1L TPI1 | 1.22e-09 | 288 | 163 | 13 | 31501420 |
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | TUBA1C TUBA3E CCT2 HNRNPA1L2 HNRNPA1 TUBA3C TUBA1A HSPA1L TPI1 | 4.34e-09 | 116 | 163 | 9 | 22810585 |
| Pubmed | 6.92e-09 | 6 | 163 | 4 | 3785200 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | NBPF12 TUBA3D TUBA3C NBPF1 RPL7L1 SQSTM1 NBPF9 NBPF10 NBPF14 HYDIN | 8.63e-09 | 170 | 163 | 10 | 23314748 |
| Pubmed | XRN2 MLEC RPN1 USP9X TUBA1C CAPZA1 DUT CAPZA2 TUBA3E CCT2 HNRNPA1L2 HNRNPA1 TUBA3C TUBA1A PA2G4 SERPINB3 MACF1 HSPA1L TPI1 | 1.90e-08 | 844 | 163 | 19 | 25963833 | |
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 3.21e-08 | 8 | 163 | 4 | 16148047 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 5.25e-08 | 22 | 163 | 5 | 23826228 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 1.45e-07 | 125 | 163 | 8 | 36030824 | |
| Pubmed | RPN1 TUBA3D TUBA1C TUBA3E TUBA3C JAK1 TUBA1B TUBA1A PA2G4 HSPA1L | 2.14e-07 | 239 | 163 | 10 | 23246001 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 2.24e-07 | 12 | 163 | 4 | 15331610 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIFBP XRN2 MLEC TRIO MYO6 RPN1 USP9X TUBA1C CAPZA1 DUT NUMA1 CAPZA2 CCT2 HNRNPA1 SACM1L FANCD2 TUBA1B RPL7L1 PA2G4 SERPINB3 SQSTM1 COASY TPI1 | 2.43e-07 | 1425 | 163 | 23 | 30948266 |
| Pubmed | 2.95e-07 | 93 | 163 | 7 | 22079093 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | MYO6 USP9X TUBA1C NUMA1 PEX1 FMNL2 ABCB1 FANCD2 JAK1 ATP11B ANKIB1 | 3.00e-07 | 313 | 163 | 11 | 38270169 |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 3.22e-07 | 13 | 163 | 4 | 10908577 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | XRN2 USP9X TUBA1C CAPZA1 NUMA1 CAPZA2 CCT2 HNRNPA1 MYO5C ABCB1 ITPR2 TUBA1B RPL7L1 PA2G4 SQSTM1 MACF1 MMAB TAP1 TPI1 | 3.78e-07 | 1024 | 163 | 19 | 24711643 |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 18400243 | ||
| Pubmed | 4.49e-07 | 14 | 163 | 4 | 12486001 | ||
| Pubmed | KIFBP POGLUT3 EMC7 MLEC MYO6 RPN1 TUBA1C HNRNPA1 ELAC2 DMXL1 ITPR2 PREB RPL7L1 GLB1 PA2G4 PRKAR2B MACF1 PPIE CRYBG3 COASY MMAB HSPA1L TPI1 | 5.10e-07 | 1487 | 163 | 23 | 33957083 | |
| Pubmed | RPN1 USP9X RPS6KA3 TUBA1C NUMA1 TUBA3E CCT2 HNRNPA1 TUBA1B TUBA1A PA2G4 TPI1 | 6.17e-07 | 411 | 163 | 12 | 36652389 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | XRN2 WEE1 USP9X CAPZA1 CAPZA2 TWF2 RUFY1 TUBA1A SQSTM1 MACF1 CRYBG3 DSCC1 HSPA1L CDCA4 | 8.05e-07 | 588 | 163 | 14 | 38580884 |
| Pubmed | MYO6 TUBA1C CAPZA1 NUMA1 CAPZA2 PEX1 TWF2 CCT2 ENY2 BRD8 PA2G4 CFDP1 PPIE | 8.72e-07 | 506 | 163 | 13 | 30890647 | |
| Pubmed | 1.06e-06 | 17 | 163 | 4 | 17360745 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KIFBP USP9X RPS6KA3 TUBA1C CAPZA1 DUT CAPZA2 IREB2 TWF2 CCT2 SCLY RUFY1 HNRNPA1 ELAC2 FANCD2 TUBA1A PA2G4 SQSTM1 MACF1 N4BP1 COASY HSPA1L | 1.34e-06 | 1455 | 163 | 22 | 22863883 |
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 1.70e-06 | 233 | 163 | 9 | 32290105 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | XRN2 ERCC6 MYO6 RPN1 TUBA1C CAPZA1 NUMA1 CAPZA2 LAMA3 CCT2 HNRNPA1 ITPR2 TUBA1B PALS1 RPL7L1 PA2G4 SERPINB3 SQSTM1 PPIE TPI1 | 1.97e-06 | 1257 | 163 | 20 | 36526897 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | XRN2 MLEC MYO6 RPN1 USP9X TUBA1C CAPZA1 CAPZA2 CCT2 HNRNPA1L2 HNRNPA1 TUBA3C ENY2 ELAC2 PREB TUBA1B TUBA1A PA2G4 SQSTM1 TPI1 | 1.97e-06 | 1257 | 163 | 20 | 37317656 |
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 12090300 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 2.00e-06 | 6 | 163 | 3 | 7651436 | |
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 16327313 | ||
| Pubmed | A transcriptional coregulator, SPIN·DOC, attenuates the coactivator activity of Spindlin1. | 2.00e-06 | 6 | 163 | 3 | 29061846 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | XRN2 USP9X TUBA1C PEX1 LAMA3 CCT2 HNRNPA1 TUBA3C MMRN1 TUBA1B GLB1 TUBA1A ANKIB1 HSPA1L | 2.13e-06 | 639 | 163 | 14 | 23443559 |
| Pubmed | XRN2 RPN1 USP9X TUBA1C CAPZA1 DUT PEX1 TUBA3E CCT2 HNRNPA1L2 NCSTN HNRNPA1 TUBA1B GLB1 TUBA1A MACF1 METTL16 HSPA1L TPI1 | 2.19e-06 | 1153 | 163 | 19 | 29845934 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | KIFBP EMC7 MYO6 RPN1 USP9X PEX1 DAG1 NCSTN URGCP SACM1L FANCD2 PREB RPL7L1 GLB1 PA2G4 SQSTM1 METTL16 | 2.34e-06 | 942 | 163 | 17 | 31073040 |
| Pubmed | Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | 2.41e-06 | 243 | 163 | 9 | 36964488 | |
| Pubmed | 2.90e-06 | 84 | 163 | 6 | 31616248 | ||
| Pubmed | 3.18e-06 | 22 | 163 | 4 | 15103018 | ||
| Pubmed | KIFBP RPN1 WEE1 RPS6KA2 CAPZA1 CAPZA2 CCT2 RPS6KC1 JAK1 JAK3 SQSTM1 | 3.34e-06 | 401 | 163 | 11 | 25852190 | |
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 20816854 | ||
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 36681692 | ||
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 11146551 | ||
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | XRN2 MYO6 CAPZA1 CAPZA2 CCT2 HNRNPA1 MYO5C TUBA1B TUBA1A SQSTM1 | 3.74e-06 | 328 | 163 | 10 | 23398456 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RPGRIP1 KIFBP XRN2 MLEC TRAF3IP1 WEE1 CAPZA1 CAPZA2 FMNL2 TUBA3C URGCP POSTN PACS1 TFPT GLB1 PA2G4 KCTD3 RPGR HSPA1L BBS12 | 4.16e-06 | 1321 | 163 | 20 | 27173435 |
| Pubmed | KIFBP XRN2 MLEC RPN1 RPS6KA3 TUBA1C CAPZA1 DUT NUMA1 CAPZA2 TWF2 CCT2 ENY2 SACM1L ITPR2 FANCD2 RPL7L1 TUBA1A PA2G4 SQSTM1 TAP1 | 4.18e-06 | 1440 | 163 | 21 | 30833792 | |
| Pubmed | 5.45e-06 | 25 | 163 | 4 | 19405953 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | COL6A3 GIPC2 MYO6 CAPZA1 CAPZA2 CCT2 NCSTN F11 ABCB1 PALS1 GLB1 TUBA1A HPD SERPINB3 SQSTM1 COASY TPI1 | 6.36e-06 | 1016 | 163 | 17 | 19056867 |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 7.12e-06 | 98 | 163 | 6 | 21942715 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | XRN2 RPN1 CAPZA1 NUMA1 CAPZA2 CCT2 HNRNPA1L2 HNRNPA1 TUBA1B TUBA1A PA2G4 SPIN2A PPIE HSPA1L | 7.55e-06 | 714 | 163 | 14 | 28302793 |
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 8.32e-06 | 9 | 163 | 3 | 11953448 | |
| Pubmed | 8.32e-06 | 9 | 163 | 3 | 19103752 | ||
| Pubmed | 1.15e-05 | 295 | 163 | 9 | 26209609 | ||
| Pubmed | POGLUT3 EMC7 MLEC TRIO RPN1 NUMA1 CCT2 NCSTN HNRNPA1 ELAC2 SACM1L JAK1 TUBA1B GLB1 SQSTM1 MACF1 ATG9A MMAB TAP1 | 1.17e-05 | 1297 | 163 | 19 | 33545068 | |
| Pubmed | XRN2 PEX1 URGCP DENND3 SACM1L PREB PACS1 PALS1 GLB1 TLL1 ANKIB1 CRYBG3 METTL16 | 1.31e-05 | 650 | 163 | 13 | 38777146 | |
| Pubmed | 1.62e-05 | 11 | 163 | 3 | 11532003 | ||
| Pubmed | 1.62e-05 | 11 | 163 | 3 | 36220570 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYO6 RPN1 TUBA1C NUMA1 HNRNPA1 TUBA1B PA2G4 SQSTM1 KCTD3 HSPA1L TPI1 | 1.70e-05 | 477 | 163 | 11 | 31300519 |
| Pubmed | KIFBP XRN2 MYO6 RPN1 USP9X CAPZA1 DUT CAPZA2 CCT2 HNRNPA1L2 HNRNPA1 FANCD2 TUBA1B PALS1 TUBA1A PPIE HSPA1L NSMCE1 TPI1 | 1.74e-05 | 1335 | 163 | 19 | 29229926 | |
| Pubmed | 1.78e-05 | 172 | 163 | 7 | 26336360 | ||
| Pubmed | 1.78e-05 | 172 | 163 | 7 | 23184937 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | MYO6 RPN1 TUBA1C CAPZA1 CCT2 FANCD2 PTPRE PA2G4 KCTD3 HSPA1L CDCA4 TPI1 | 1.82e-05 | 573 | 163 | 12 | 28330616 |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | WEE1 TUBA1C CAPZA1 CAPZA2 HNRNPA1 TUBA3C TUBA1A KCTD3 HSPA1L | 2.03e-05 | 317 | 163 | 9 | 17620599 |
| Pubmed | 2.07e-05 | 176 | 163 | 7 | 28692057 | ||
| Pubmed | 2.16e-05 | 12 | 163 | 3 | 37143315 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 32960212 | ||
| Pubmed | siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. | 2.18e-05 | 2 | 163 | 2 | 15215364 | |
| Pubmed | Phosphorylation of hnRNP A1-Serine 199 Is Not Required for T Cell Differentiation and Function. | 2.18e-05 | 2 | 163 | 2 | 38334757 | |
| Pubmed | Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers. | 2.18e-05 | 2 | 163 | 2 | 18559588 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 10920239 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 32877908 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 10958648 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 10958647 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 20827784 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 28912364 | ||
| Pubmed | Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma. | 2.18e-05 | 2 | 163 | 2 | 20697856 | |
| Pubmed | Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia. | 2.18e-05 | 2 | 163 | 2 | 24048415 | |
| Pubmed | Mechanism of Janus kinase 3-catalyzed phosphorylation of a Janus kinase 1 activation loop peptide. | 2.18e-05 | 2 | 163 | 2 | 12559972 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19190184 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31257225 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 11104772 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25328666 | ||
| Pubmed | Regulation of mouse hepatitis virus RNA synthesis by heterogeneous nuclear ribonucleoprotein A1. | 2.18e-05 | 2 | 163 | 2 | 11774503 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 11774505 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8041722 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12560094 | ||
| Pubmed | Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors. | 2.18e-05 | 2 | 163 | 2 | 25352124 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 1406633 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 32748110 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17160889 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 28220845 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12140192 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 29530480 | ||
| Pubmed | hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis. | 2.18e-05 | 2 | 163 | 2 | 36382566 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 11495723 | ||
| Interaction | NEK4 interactions | RPGRIP1 COL6A3 NBPF12 ERCC6 TRIO MYO6 RPN1 CAPZA1 TUBA3E HNRNPA1 TUBA3C NBPF1 TUBA1B NBPF15 TUBA1A NBPF9 NBPF10 RPGR NBPF14 HSPA1L | 4.37e-08 | 582 | 161 | 20 | int:NEK4 |
| Interaction | TCP11L2 interactions | 5.61e-07 | 21 | 161 | 5 | int:TCP11L2 | |
| Interaction | MCM2 interactions | XRN2 MLEC RPN1 WEE1 USP9X TUBA1C CAPZA1 DUT NUMA1 CAPZA2 TUBA3E CCT2 HNRNPA1L2 HNRNPA1 TUBA3C FANCD2 TUBA1A PA2G4 SERPINB3 MACF1 SPIN2B HSPA1L TPI1 | 1.68e-05 | 1081 | 161 | 23 | int:MCM2 |
| Interaction | RHOA interactions | EMC7 TRIO MYO6 RPN1 USP9X TUBA1C DAG1 RUFY1 FMNL2 BTN3A2 ITPR2 FANCD2 PREB JAK1 RHPN1 TUBA1B PALS1 GLB1 MACF1 PPIE RPGR ATG9A TAP1 CYB5A | 2.93e-05 | 1199 | 161 | 24 | int:RHOA |
| Interaction | GABRA1 interactions | 3.09e-05 | 152 | 161 | 8 | int:GABRA1 | |
| Interaction | SH3BGRL interactions | 3.09e-05 | 152 | 161 | 8 | int:SH3BGRL | |
| Cytoband | 12q13.12 | 2.42e-07 | 38 | 163 | 5 | 12q13.12 | |
| Cytoband | Xp11.1 | 7.48e-05 | 4 | 163 | 2 | Xp11.1 | |
| Cytoband | 16q12.1 | 2.42e-04 | 34 | 163 | 3 | 16q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q21 | 4.55e-04 | 178 | 163 | 5 | chr7q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 6.38e-04 | 404 | 163 | 7 | chr1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 8.34e-04 | 423 | 163 | 7 | chr12q13 | |
| Cytoband | 7q21.2 | 1.28e-03 | 15 | 163 | 2 | 7q21.2 | |
| Cytoband | 1q21.1 | 1.43e-03 | 62 | 163 | 3 | 1q21.1 | |
| Cytoband | 1q41 | 1.71e-03 | 66 | 163 | 3 | 1q41 | |
| GeneFamily | Neuroblastoma breakpoint family | 6.59e-13 | 23 | 110 | 8 | 662 | |
| GeneFamily | Tubulins | 9.22e-09 | 26 | 110 | 6 | 778 | |
| GeneFamily | Tudor domain containing|Spindlin family | 2.17e-06 | 5 | 110 | 3 | 1089 | |
| GeneFamily | Chaperonins | 9.45e-05 | 15 | 110 | 3 | 587 | |
| GeneFamily | Tudor domain containing | 1.46e-03 | 37 | 110 | 3 | 780 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 1.95e-03 | 11 | 110 | 2 | 1156 | |
| GeneFamily | ATP binding cassette subfamily B | 1.95e-03 | 11 | 110 | 2 | 806 | |
| GeneFamily | Oligosaccharyltransferase complex subunits | 2.33e-03 | 12 | 110 | 2 | 445 | |
| GeneFamily | Gla domain containing | 2.74e-03 | 13 | 110 | 2 | 1250 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 3.66e-03 | 15 | 110 | 2 | 458 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 5.86e-03 | 19 | 110 | 2 | 50 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 7.14e-03 | 21 | 110 | 2 | 980 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL6A3 POGLUT3 XRN2 GIPC2 AMACR DUT ANO1 RUFY1 MYO5C ABCB1 ITPR2 PREB CCDC13 TUBA1A XIRP2 PA2G4 SQSTM1 CFDP1 COASY DSCC1 NSMCE1 | 7.46e-06 | 1136 | 162 | 21 | M2247 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL6A3 POGLUT3 XRN2 GIPC2 AMACR DUT ANO1 RUFY1 MYO5C ABCB1 ITPR2 PREB CCDC13 TUBA1A XIRP2 PA2G4 SQSTM1 CFDP1 COASY DSCC1 NSMCE1 | 1.66e-05 | 1198 | 162 | 21 | MM1062 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | KIFBP EMC7 MLEC RPN1 R3HCC1 NUMA1 AGGF1 CCT2 E4F1 HNRNPA1L2 HNRNPA1 PREB JAK1 PACS1 RPL7L1 PA2G4 CFDP1 COASY NSMCE1 TPI1 | 3.30e-05 | 1158 | 162 | 20 | MM1338 |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN | 3.49e-05 | 199 | 162 | 8 | M8707 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN | 3.62e-05 | 200 | 162 | 8 | M4531 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN | 3.62e-05 | 200 | 162 | 8 | M4022 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | XRN2 MLEC MYO6 WEE1 RPS6KA2 TUBA1C CAPZA1 VTCN1 LAMA3 DAG1 CCT2 RALGAPA2 FMNL2 ABCB1 ITPR2 ATP11B GLB1 SQSTM1 MACF1 JPT1 TPI1 | 4.17e-05 | 1276 | 162 | 21 | M39173 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | XRN2 USP9X RPS6KA3 CAPZA1 HECTD4 NUMA1 AGGF1 TWF2 BTN3A2 ABCB1 SACM1L ITPR2 JAK1 JAK3 PACS1 KMT2D DENND1B PTPRE ATP11B TUBA1A MACF1 N4BP1 TAP1 | 4.80e-05 | 1492 | 162 | 23 | M40023 |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_2_DN | 6.31e-05 | 279 | 162 | 9 | M16867 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | KIFBP EMC7 MLEC RPN1 R3HCC1 NUMA1 AGGF1 CCT2 E4F1 HNRNPA1 PREB JAK1 PACS1 RPL7L1 PA2G4 CFDP1 COASY NSMCE1 TPI1 | 7.42e-05 | 1129 | 162 | 19 | M42508 |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-07 | 157 | 163 | 8 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 6.56e-07 | 196 | 163 | 8 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | COVID-19_Severe-PLT_0|World / Disease Group and Platelet Clusters | 7.08e-07 | 198 | 163 | 8 | d508d69d8de233573aee14f17dd8ef054654aa54 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.96e-06 | 176 | 163 | 7 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.26e-06 | 193 | 163 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 8.30e-06 | 197 | 163 | 7 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.57e-06 | 198 | 163 | 7 | cd876fba12ff30b74aa507286cb1f3a867011a92 | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 8.86e-06 | 199 | 163 | 7 | 72c96a5954dfcfbfee8f095984ce1f5249d9a679 | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 8.86e-06 | 199 | 163 | 7 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.15e-06 | 200 | 163 | 7 | c55efd997392e99068b673542f56f1a209c5a6c8 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Bronchial_vessel|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.15e-06 | 200 | 163 | 7 | a18817d36b2b30a32e1513d36174bf98dfea2a92 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.15e-06 | 200 | 163 | 7 | 71979bbcc035d5b8882f1502b5a8ef248aaba45a | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 165 | 163 | 6 | dba630e205eb3725195f8861e4af5b745ccfdc74 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 165 | 163 | 6 | a508d66031c1a46b062afbee3cde1cbd0c163a03 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 165 | 163 | 6 | b03c8c3110f32257e78838885b313a922af73c98 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.51e-05 | 167 | 163 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-05 | 169 | 163 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 4.13e-05 | 172 | 163 | 6 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | BAL-Mild-cDC_3|Mild / Compartment, Disease Groups and Clusters | 4.70e-05 | 176 | 163 | 6 | f9b0c3ced391e7ebe6b242d3f12ba14741f88d22 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.85e-05 | 177 | 163 | 6 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-05 | 182 | 163 | 6 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.84e-05 | 183 | 163 | 6 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 5.84e-05 | 183 | 163 | 6 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.02e-05 | 184 | 163 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.02e-05 | 184 | 163 | 6 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 6.20e-05 | 185 | 163 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.20e-05 | 185 | 163 | 6 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 6.20e-05 | 185 | 163 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.20e-05 | 185 | 163 | 6 | 46f4f6f20b1e152922f6f2ba1244c56e48a49b79 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.58e-05 | 187 | 163 | 6 | 1399c703505211c510b3f14c7a2aa9930566c473 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.58e-05 | 187 | 163 | 6 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.58e-05 | 187 | 163 | 6 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.58e-05 | 187 | 163 | 6 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-05 | 189 | 163 | 6 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-05 | 189 | 163 | 6 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.98e-05 | 189 | 163 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-05 | 189 | 163 | 6 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-05 | 190 | 163 | 6 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.18e-05 | 190 | 163 | 6 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.18e-05 | 190 | 163 | 6 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-05 | 190 | 163 | 6 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.18e-05 | 190 | 163 | 6 | 088e3f39a1e5e11354d6e7458e8e6a39f14936b3 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.18e-05 | 190 | 163 | 6 | 35248a8be476ea8d06d67c3d98a25be1f7c150b7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-05 | 190 | 163 | 6 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-05 | 190 | 163 | 6 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.18e-05 | 190 | 163 | 6 | 5f5206f9e725070d865f4c891ff08bb750e58582 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-05 | 190 | 163 | 6 | 6b704deeb44e1ffa10e604d0e5612b022f6cd9a6 | |
| ToppCell | severe-Platelet|severe / disease stage, cell group and cell class | 7.18e-05 | 190 | 163 | 6 | 497ec3fe4dd6f1b4fa6e76d9ac07df497efce7a2 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.39e-05 | 191 | 163 | 6 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.39e-05 | 191 | 163 | 6 | 6a8fc9dc1a4c7115862e8f20204fa2f95e50e22f | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 7.61e-05 | 192 | 163 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-05 | 192 | 163 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 7.61e-05 | 192 | 163 | 6 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.06e-05 | 194 | 163 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.29e-05 | 195 | 163 | 6 | d35102f95bb1e419d2df05ff0a01b6c5c923acef | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.29e-05 | 195 | 163 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 8.52e-05 | 196 | 163 | 6 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.52e-05 | 196 | 163 | 6 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.52e-05 | 196 | 163 | 6 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-05 | 197 | 163 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | CV-Severe-0|Severe / Virus stimulation, Condition and Cluster | 8.76e-05 | 197 | 163 | 6 | d13fc20b31ab6d9117437fba319c72f3a552858f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-05 | 197 | 163 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-05 | 197 | 163 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | COVID-19_Severe-PLT_0|COVID-19_Severe / Disease Group and Platelet Clusters | 8.76e-05 | 197 | 163 | 6 | dbdeefa72d10f2c5f75ad5aac6f31a892d4e94a9 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 8.76e-05 | 197 | 163 | 6 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-05 | 197 | 163 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.01e-05 | 198 | 163 | 6 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.01e-05 | 198 | 163 | 6 | 5c82dad416938d5c460069796d808170e7dbc8d9 | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.01e-05 | 198 | 163 | 6 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.01e-05 | 198 | 163 | 6 | d5996bd3756fcd4d5866006da2ecd923f0f25427 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.01e-05 | 198 | 163 | 6 | 8bd9be3f57e7a27935c63c913e486872d52600e7 | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 9.01e-05 | 198 | 163 | 6 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 9.26e-05 | 199 | 163 | 6 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.26e-05 | 199 | 163 | 6 | 4394dcd1809f49e9bada8f5e115d5123356eae3e | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_Plasmablasts|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.26e-05 | 199 | 163 | 6 | 624a807fae0a080a4e6755dcb374c25b6f2d2cfe | |
| ToppCell | COVID-19_Severe-PLT_5|COVID-19_Severe / Disease Group and Platelet Clusters | 9.26e-05 | 199 | 163 | 6 | 93e814f45b220687007c75f20ec1ea25234f7d65 | |
| ToppCell | remission-T/NK_proliferative|remission / disease stage, cell group and cell class | 9.26e-05 | 199 | 163 | 6 | 303a5fc43a48b05b6f2060d99eef4adc36f8d4e3 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.26e-05 | 199 | 163 | 6 | c0ea391bb347b99b94b5d7f02612ede938986745 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.26e-05 | 199 | 163 | 6 | 96af1f289552f38f2dfa181192eb3276f4c7d70b | |
| ToppCell | remission-T/NK_proliferative|World / disease stage, cell group and cell class | 9.26e-05 | 199 | 163 | 6 | f305f3a454b7d2170429bad087480ccccca19acd | |
| ToppCell | 390C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.26e-05 | 199 | 163 | 6 | 60c658e0b709a6c413e9b014a26b453cada85619 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease group, lineage and cell class | 9.26e-05 | 199 | 163 | 6 | 893b78c661c529db07a5fcc3124d9b3d0f270fa5 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.26e-05 | 199 | 163 | 6 | 5b18e18ddbf4bd53aa0d574d23092cb96da7f400 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.26e-05 | 199 | 163 | 6 | 6df65f4c2f9a125e0c7c4f597fefc05a97fc8831 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.26e-05 | 199 | 163 | 6 | cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.26e-05 | 199 | 163 | 6 | 29ed081bd5204a32068b420f2244f3704891547b | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.26e-05 | 199 | 163 | 6 | c2d85f80037f209a4a329790f475d9f98f590262 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.52e-05 | 200 | 163 | 6 | 5f2fbd789cc16af411a01c3199583888b260ae91 | |
| ToppCell | (5)_Plasma-(5)_Plasmablast|(5)_Plasma / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 9.52e-05 | 200 | 163 | 6 | bba54e9acc7514e123de083a4eb49e7bcdb3dac3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | eac33be484dc443794e66e473f03e98406c2983e | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 9.52e-05 | 200 | 163 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.52e-05 | 200 | 163 | 6 | d92d3bc63a56a604d7b1d49e62d4304e5e4017f2 | |
| ToppCell | MS-Multiple_Sclerosis-Others-Platelet|Multiple_Sclerosis / Disease, condition lineage and cell class | 9.52e-05 | 200 | 163 | 6 | 263d956136747c209951b4358f2e1672a21d8eef | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.52e-05 | 200 | 163 | 6 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | ILEUM-inflamed-(1)_Highly_activated_T_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.52e-05 | 200 | 163 | 6 | 6ff811fdfe49b5b0aea0e88fae80bfaaf40eb7c4 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.52e-05 | 200 | 163 | 6 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.52e-05 | 200 | 163 | 6 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.88e-04 | 144 | 163 | 5 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_atypical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 148 | 163 | 5 | b7b5521162effc1024e7c399f690cd86d0b2f750 | |
| Drug | Epothilone D | 1.09e-06 | 12 | 159 | 4 | DB01873 | |
| Drug | Epothilone B | 1.09e-06 | 12 | 159 | 4 | DB03010 | |
| Drug | Pesticides | 1.13e-06 | 150 | 159 | 9 | ctd:D010575 | |
| Drug | Z)-combretastatin A-4 | 1.30e-06 | 50 | 159 | 6 | CID000072686 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1.33e-06 | 4 | 159 | 3 | DB07574 | |
| Drug | 2-phenyl-4-quinolone | 3.68e-06 | 34 | 159 | 5 | CID000161091 | |
| Drug | ixabepilone | 8.80e-06 | 69 | 159 | 6 | CID006445540 | |
| Drug | fluorescein-colchicine | 1.83e-05 | 23 | 159 | 4 | CID003035871 | |
| Drug | CA1P | 2.58e-05 | 25 | 159 | 4 | CID006918545 | |
| Drug | indibulin | 3.04e-05 | 26 | 159 | 4 | CID000002929 | |
| Drug | NSC D-669356 | 3.55e-05 | 27 | 159 | 4 | CID000178028 | |
| Drug | S)-monastrol | 3.74e-05 | 54 | 159 | 5 | CID000794323 | |
| Drug | NSC 370147 | 4.11e-05 | 28 | 159 | 4 | CID000182762 | |
| Drug | lithium indium | 4.85e-05 | 2 | 159 | 2 | CID011116062 | |
| Drug | scandium phosphate | 4.85e-05 | 2 | 159 | 2 | CID006365269 | |
| Drug | rubidium nitrate | 4.85e-05 | 2 | 159 | 2 | CID000025731 | |
| Drug | tert-butylphenol | 5.29e-05 | 11 | 159 | 3 | CID000006923 | |
| Drug | eleutherobin | 5.45e-05 | 30 | 159 | 4 | CID006918335 | |
| Drug | azatoxin | 5.45e-05 | 30 | 159 | 4 | CID000125383 | |
| Drug | NSC617668 | 5.45e-05 | 30 | 159 | 4 | CID000357989 | |
| Disease | microlissencephaly (implicated_via_orthology) | 5.09e-13 | 8 | 154 | 6 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 5.09e-13 | 8 | 154 | 6 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 5.09e-13 | 8 | 154 | 6 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 7.48e-11 | 27 | 154 | 7 | DOID:0050453 (implicated_via_orthology) | |
| Disease | Obesity | 1.06e-04 | 205 | 154 | 7 | C0028754 | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 1.61e-04 | 4 | 154 | 2 | DOID:3783 (implicated_via_orthology) | |
| Disease | response to bevacizumab, Proteinuria | 2.68e-04 | 5 | 154 | 2 | EFO_0005943, HP_0000093 | |
| Disease | retinol measurement | 4.00e-04 | 6 | 154 | 2 | EFO_0007900 | |
| Disease | Age related macular degeneration | 5.10e-04 | 30 | 154 | 3 | C0242383 | |
| Disease | Developmental Psychomotor Disorders | 5.59e-04 | 7 | 154 | 2 | C0751456 | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 5.59e-04 | 7 | 154 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | Psychomotor Disorders | 5.59e-04 | 7 | 154 | 2 | C0033922 | |
| Disease | laurylcarnitine measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0021041 | |
| Disease | Retinal Dystrophies | 7.42e-04 | 8 | 154 | 2 | C0854723 | |
| Disease | cortical thickness | ZNF438 ADAMTS3 ADAMTS2 RPS6KA2 CAPZA1 RUFY1 FMNL2 HNRNPA1L3 ELAC2 DENND3 SACM1L ENO4 DENND1B KCTD3 MACF1 | 7.51e-04 | 1113 | 154 | 15 | EFO_0004840 |
| Disease | cystic fibrosis (implicated_via_orthology) | 9.51e-04 | 9 | 154 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | epilepsy (is_implicated_in) | 9.51e-04 | 9 | 154 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | Motor retardation | 9.51e-04 | 9 | 154 | 2 | C0424230 | |
| Disease | Drug toxicity | 9.96e-04 | 84 | 154 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 9.96e-04 | 84 | 154 | 4 | C0041755 | |
| Disease | Amyloidosis | 1.18e-03 | 10 | 154 | 2 | C0002726 | |
| Disease | disposition index measurement, glucose homeostasis measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0006832, EFO_0006896 | |
| Disease | Microphthalmos | 1.44e-03 | 11 | 154 | 2 | C0026010 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 1.44e-03 | 11 | 154 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of esophagus | 1.57e-03 | 95 | 154 | 4 | C0279626 | |
| Disease | Inhalant adrenergic use measurement | 1.63e-03 | 96 | 154 | 4 | EFO_0009941 | |
| Disease | retinal vasculature measurement | 1.64e-03 | 517 | 154 | 9 | EFO_0010554 | |
| Disease | mean corpuscular hemoglobin concentration | XRN2 GIPC2 RPN1 TUBA1C HECTD4 DAG1 IREB2 HNRNPA1 DMXL1 ITPR2 ATP11B HPD MACF1 MMAB | 2.01e-03 | 1105 | 154 | 14 | EFO_0004528 |
| Disease | myopathy (implicated_via_orthology) | 2.03e-03 | 48 | 154 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | hematologic cancer (implicated_via_orthology) | 2.03e-03 | 13 | 154 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | ZNF438 ADAMTS3 HNRNPA1L3 ELAC2 DENND3 SACM1L TUBA1B DENND1B MACF1 | 2.48e-03 | 550 | 154 | 9 | EFO_0004346, EFO_0004464 |
| Disease | Ciliopathies | 2.68e-03 | 110 | 154 | 4 | C4277690 | |
| Disease | cortical thickness, neuroimaging measurement | 2.68e-03 | 110 | 154 | 4 | EFO_0004346, EFO_0004840 | |
| Disease | pyruvate measurement | 2.91e-03 | 268 | 154 | 6 | EFO_0010117 | |
| Disease | Polydactyly | 3.35e-03 | 117 | 154 | 4 | C0152427 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 3.50e-03 | 17 | 154 | 2 | C2936862 | |
| Disease | factor XI measurement, Ischemic stroke | 3.50e-03 | 17 | 154 | 2 | EFO_0004694, HP_0002140 | |
| Disease | response to clozapine | 3.92e-03 | 18 | 154 | 2 | GO_0097338 | |
| Disease | Bardet-Biedl syndrome | 3.92e-03 | 18 | 154 | 2 | cv:C0752166 | |
| Disease | Post-Traumatic Osteoporosis | 4.02e-03 | 61 | 154 | 3 | C0751406 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 4.02e-03 | 61 | 154 | 3 | C1961102 | |
| Disease | Osteoporosis, Senile | 4.02e-03 | 61 | 154 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 4.02e-03 | 61 | 154 | 3 | C0001787 | |
| Disease | neuroimaging measurement | ZNF438 ADAMTS3 SZT2 RUFY1 HNRNPA1L3 ELAC2 DENND3 JAK1 ENO4 TUBA1B SEMA3D DENND1B MACF1 | 4.09e-03 | 1069 | 154 | 13 | EFO_0004346 |
| Disease | Malignant neoplasm of breast | ZNF438 ERCC6 ACHE RPS6KA3 RUFY1 BTN3A2 ABCB1 RGL1 KMT2D IL1RAPL2 TLL1 FKBPL MACF1 | 4.25e-03 | 1074 | 154 | 13 | C0006142 |
| Disease | Osteoporosis | 4.40e-03 | 63 | 154 | 3 | C0029456 | |
| Disease | Headache | 4.60e-03 | 64 | 154 | 3 | HP_0002315 | |
| Disease | cortical surface area measurement | ZNF438 ADAMTS3 TUBA1C DUT FMNL2 HNRNPA1L3 ELAC2 DENND3 SACM1L SEMA3D DENND1B TUBA1A TLL1 FKBPL MACF1 | 4.64e-03 | 1345 | 154 | 15 | EFO_0010736 |
| Disease | Astigmatism | 4.74e-03 | 129 | 154 | 4 | HP_0000483 | |
| Disease | Alzheimer's disease (is_implicated_in) | 5.14e-03 | 132 | 154 | 4 | DOID:10652 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DFHGLQVLVGVVKDE | 351 | P22303 | |
| EKGLEHVTVDDLVAE | 56 | Q9NPA8 | |
| HIEVKGYEDGGIHLE | 151 | O00478 | |
| VVDIEKIHGTGLELT | 1866 | Q68DQ2 | |
| VGDIIAIIEDKVDDH | 416 | Q9H0E9 | |
| EHEVGEAIREKIAEG | 61 | P51857 | |
| IGEHTEEILEEFGFS | 346 | Q9UHK6 | |
| KIEGYEDQVLITEHG | 66 | P52907 | |
| VGDEVFIKLDGGKVH | 206 | Q86Z23 | |
| VELLVKHGGDLFAEN | 161 | Q9P2G1 | |
| HGDEVKIGETVLSFH | 501 | Q8N302 | |
| LGLEDFIFAHVKGIE | 101 | Q8TF65 | |
| DHFEEVSKEADGLVL | 271 | A2RUS2 | |
| DTDLIEELHGLKDVA | 166 | Q6ZW61 | |
| SGIGVFELVDDHFVE | 206 | Q8TAM1 | |
| EVETKGSEDFLVIHA | 2686 | Q9Y485 | |
| GAEVKIELDHASLEE | 201 | Q03468 | |
| LLGVDDSVVQFHGKE | 271 | O95450 | |
| FVEELPGEKDLAHVV | 306 | Q9Y3T6 | |
| KIFVGGIKEDTEEHH | 106 | Q32P51 | |
| KIFVGGIKEDTEEHH | 61 | A0A2R8Y4L2 | |
| DEVDILGLDGHIYKG | 1591 | Q9H0J4 | |
| GEEVEEGAVYHVTLK | 16 | Q9NZL6 | |
| IEKHGLSAVGIFTLE | 246 | Q6ZRI8 | |
| VESEHQVKIGDFGLT | 1011 | P23458 | |
| EDDVEITLYKHGGLL | 941 | P48200 | |
| LVESEAHVKIADFGL | 956 | P52333 | |
| EDVLKGGDVVRLFHA | 231 | Q14571 | |
| ISGDTGVIHVVEKEE | 66 | Q92542 | |
| FDDGVIVEKGNHDEL | 601 | P08183 | |
| GAEVKIELDHASLEE | 201 | P0DP91 | |
| KEGDLVKIDLGVHVD | 101 | Q9UQ80 | |
| GTTTHFDKIGLEEEF | 416 | P23469 | |
| VTAVELEEEEKHGGL | 526 | Q8TDR0 | |
| VVFGHDGEKGRLVVD | 3071 | Q16787 | |
| ESGLVLEGDKEIHQI | 871 | Q96S38 | |
| AHISGFLVVDGIDKL | 1156 | Q13201 | |
| GHVVVKDLDIFDRVG | 146 | Q14165 | |
| LDEEGHIKLTDFGLS | 201 | P51812 | |
| LGDDVVLFTTDGAHK | 211 | P16278 | |
| DKGGLSAVDAFEIHV | 581 | Q14118 | |
| EKAEELIHLITGEFS | 4656 | Q5CZC0 | |
| VAELELDAVIGFNGH | 11 | Q8N1V2 | |
| GIVVSVLDDGIEKDH | 151 | Q6UW60 | |
| DLTKFLEEHPGGEEV | 36 | P00167 | |
| LDLKGEGDIHENVDT | 96 | Q9UK76 | |
| EGGELEFVKRIIHDS | 221 | Q86W50 | |
| DGIFEVKATAGDTHL | 216 | P34931 | |
| ELERDEDTKIHGVGF | 141 | Q5XXA6 | |
| LAAKHFIDVGAGVID | 176 | P33316 | |
| LKTFGLHGVVLDVDS | 2366 | Q9Y4D8 | |
| GDDVLDKLLENIGHT | 1516 | Q2PPJ7 | |
| EKHVGFSLDVGEIEK | 1086 | Q3BBV0 | |
| TKDGFHLVIELEDLG | 146 | Q6UXL0 | |
| VEGAKHQLEIFDALG | 5031 | Q9UPN3 | |
| FKVSDEVGFGLEHVS | 341 | Q6VY07 | |
| KSGLLHEGDEVLEIN | 291 | Q8N3R9 | |
| ITESGKFHVDDEGTL | 551 | A1KZ92 | |
| DILELVDGHFDTKIG | 171 | Q9UHY7 | |
| AEVLFHDDGSVKGIA | 201 | Q16134 | |
| LLGVDDSVVRFHGKE | 261 | O15072 | |
| FKEEEGIGEELAIHN | 251 | Q9UEE9 | |
| EHTQGAEKLVAELEG | 61 | Q9UIM3 | |
| HVDLQDELGVFSLKG | 3521 | Q4G0P3 | |
| GAITLLEFKRHVGEE | 41 | A0AVF1 | |
| LEKFIPDHSEGVVET | 1051 | Q6AI39 | |
| LEDGHSLVIRGDKDE | 56 | Q9BVC3 | |
| VKIHQTEGDGDVLAF | 266 | Q9H5Z1 | |
| GEEDLLVHVAEGSKS | 21 | Q7Z3C6 | |
| GTLVEKGRHDDELID | 371 | Q8IYE1 | |
| KVVIHFTDGADGDLA | 1946 | P12111 | |
| FLGEELDIVAAKSHE | 301 | P03951 | |
| HVEVKGYEDGGIHLE | 151 | P78410 | |
| RHVYEGKDGAIEDII | 1041 | Q96PY5 | |
| EELVQNGTLGFKEEH | 566 | A6NNW6 | |
| VEEGVHQLEKVDGVL | 311 | Q1MX18 | |
| FEKLVKDGEHVIDQG | 171 | P31323 | |
| EEKASVFVEIDLGDH | 151 | A0A1B0GUA9 | |
| RVLVDGEEHVGFLKT | 66 | Q9NPA0 | |
| GHIKEVIVAAEAELG | 141 | Q66K89 | |
| RKEIFGTEGVDIVLH | 551 | A5D8W1 | |
| ILGAKEGTQEFVHTE | 1176 | Q9C0D2 | |
| AKETSEDIGLLHEVV | 736 | Q6P3S1 | |
| GGLAEEVDDKVLHAA | 11 | Q9UNP9 | |
| KHVVFGEVTEGLDVL | 261 | Q9UNP9 | |
| GVLHVGQKLEEQDEF | 416 | Q9NTJ5 | |
| TDAVIDIEGVGLFKE | 3036 | Q6ZTR5 | |
| ELDSGLEVHKIAEGF | 721 | Q9Y597 | |
| DLDLQHVAKETGGFV | 766 | O43933 | |
| IDTEELSAGEEHLVK | 106 | Q96EK5 | |
| EKEGEFTLHGRAILE | 161 | Q8WV22 | |
| EHTESILKAIEEIAG | 1191 | Q9BXW9 | |
| IGFALELVTEKGHTF | 96 | Q96EY8 | |
| EKVLILHGGVSDITD | 286 | O14830 | |
| ELAVILKFVLDHEDG | 126 | Q14980 | |
| APHRGVAKEIEFDEI | 366 | Q92834 | |
| LVKHGDGVKDIAFEV | 86 | P32754 | |
| ELLEAVHAKSIGDID | 3306 | Q5T011 | |
| GIEETILEGHLGVTK | 1421 | Q93008 | |
| GDEDKVDISLLHQGE | 611 | Q96KN7 | |
| HLEVFDGETEKSPIL | 831 | O43897 | |
| QDIEKTGAEDHLGIT | 126 | A0AVI2 | |
| ALEEKHVGFSLDVGE | 981 | P0DPF3 | |
| LEEKHVGFSLDVGEI | 1301 | Q6P3W6 | |
| EEKHVGFSLDVGEIE | 1546 | Q6P3W6 | |
| EKHVGFSLDVGEIEK | 1791 | Q6P3W6 | |
| ALEEKHVGFSLDVGE | 2276 | Q6P3W6 | |
| LEEKHVGFSLDVGEI | 2521 | Q6P3W6 | |
| EEKHVGFSLDVGEIE | 2766 | Q6P3W6 | |
| EKHVGFSLDVGEIEK | 3011 | Q6P3W6 | |
| ALEEKHVGFSLDVGE | 3496 | Q6P3W6 | |
| EKHVGFSLDVGEIEK | 1086 | Q5TAG4 | |
| ALEEKHVGFSLDVGE | 791 | Q5TI25 | |
| ALEEKHVGFSLDVGE | 541 | Q8N660 | |
| ALEEKHVGFSLDVGE | 541 | A0A087WUL8 | |
| LEEKHVGFSLDVGEI | 786 | A0A087WUL8 | |
| EEKHVGFSLDVGEIE | 1031 | A0A087WUL8 | |
| EKHVGFSLDVGEIEK | 1276 | A0A087WUL8 | |
| ALEEKHVGFSLDVGE | 1761 | A0A087WUL8 | |
| LEEKHVGFSLDVGEI | 2006 | A0A087WUL8 | |
| EEKHVGFSLDVGEIE | 2251 | A0A087WUL8 | |
| EKHVGFSLDVGEIEK | 2496 | A0A087WUL8 | |
| ALEEKHVGFSLDVGE | 2981 | A0A087WUL8 | |
| LEEKHVGFSLDVGEI | 3226 | A0A087WUL8 | |
| EEKHVGFSLDVGEIE | 3471 | A0A087WUL8 | |
| EKHVGFSLDVGEIEK | 3716 | A0A087WUL8 | |
| ALEEKHVGFSLDVGE | 441 | P0DPF2 | |
| LEEKHVGFSLDVGEI | 686 | P0DPF2 | |
| EEKHVGFSLDVGEIE | 931 | P0DPF2 | |
| EKHVGFSLDVGEIEK | 1176 | P0DPF2 | |
| ALEEKHVGFSLDVGE | 1661 | P0DPF2 | |
| LEEKHVGFSLDVGEI | 1906 | P0DPF2 | |
| EEKHVGFSLDVGEIE | 2151 | P0DPF2 | |
| EKHVGFSLDVGEIEK | 2396 | P0DPF2 | |
| ALEEKHVGFSLDVGE | 2881 | P0DPF2 | |
| LEEKHVGFSLDVGEI | 3126 | P0DPF2 | |
| EEKHVGFSLDVGEIE | 3371 | P0DPF2 | |
| EKHVGFSLDVGEIEK | 3616 | P0DPF2 | |
| ALEEKHVGFSLDVGE | 4101 | P0DPF2 | |
| LEEKHVGFSLDVGEI | 4346 | P0DPF2 | |
| EEKHVGFSLDVGEIE | 4516 | P0DPF2 | |
| EKHVGFSLDVGEIEK | 4836 | P0DPF2 | |
| LTDNTVIEEHLGKFG | 176 | Q6DKI1 | |
| VIEEHLGKFGVICLE | 181 | Q6DKI1 | |
| KFIEELAGHIREGEI | 286 | Q9NP60 | |
| HLGEKEVELALIFDS | 306 | Q9NP60 | |
| AVHKDLVFIVAEGDS | 426 | Q9NVX7 | |
| DLDGGKEHERITDVL | 291 | Q96T51 | |
| LAHLGVQVKGEDEEE | 81 | P04843 | |
| EDKLIHFSGVALGEA | 356 | P78371 | |
| VEQADHILFLEGGAI | 706 | Q03518 | |
| VDGLIGKHVEYTKED | 206 | Q99865 | |
| VILLEDGEICEKGTH | 671 | Q96J65 | |
| LKELISVHFGEDGAS | 126 | Q8TCX5 | |
| SGVLHKAFVEVTEEG | 326 | P29508 | |
| LGIEVDIDVEHGGKR | 251 | Q13501 | |
| ISHETADEKVIFGIE | 591 | O95025 | |
| KIEGYEDQVLITEHG | 66 | P47755 | |
| VGHEEDVEGALAGLK | 11 | Q9BXL8 | |
| VVEAFGTDILHKDGI | 406 | Q13057 | |
| IGGEIEKTRIHVDEF | 606 | Q9Y2G3 | |
| GVEEDFHIGEKKVEA | 286 | O43298 | |
| EIIGGDVQTTKHLFE | 691 | A4UGR9 | |
| DEGLKIEVLYGDEHV | 111 | Q7Z4H8 | |
| EFKAHEGEIEDLALG | 191 | Q9HCU5 | |
| EEAELLVKLDHEGVT | 2456 | O15417 | |
| IEVELLGKGHSDLGE | 6 | Q8TCY9 | |
| GHYTIGKEIVDLVLD | 106 | P0DPH8 | |
| EDLGVDFLTIVGHKF | 246 | Q96I15 | |
| TTEFHELEKIGSGEF | 296 | P30291 | |
| LGGEVVVLAKAHTDF | 491 | Q96KV7 | |
| GKSITHEGREILAEE | 281 | Q9BQ52 | |
| LFGGHILESELETEV | 31 | P0C1Z6 | |
| DSLIGKAVEHVFEGE | 116 | Q56A73 | |
| VDGLIGKHVEYTKED | 206 | Q9BPZ2 | |
| QGEDFLLHKSIDVTG | 196 | A6NJL1 | |
| HGIQGKFSLDEEAIL | 716 | Q9H0D6 | |
| GHYTIGKEIVDLVLD | 106 | P0DPH7 | |
| QGEDFLLHKSIDVTG | 196 | Q9BUG6 | |
| HVFGESDELIGQKVA | 101 | P60174 | |
| QGECLHFGIKTLEEI | 206 | A0A1B0GTU1 | |
| LVDFHKEEIITVSGG | 396 | Q5SQS7 | |
| EEQLIELIEKYGVGH | 461 | Q5SXM2 | |
| GHYTIGKEIIDLVLD | 106 | Q71U36 | |
| GHYTIGKEIVDLVLD | 106 | Q6PEY2 | |
| HGLTTEEEFVEGIYK | 76 | P02766 | |
| DLEETDKVLHGLEVS | 226 | P10072 | |
| DKVLHGLEVSGFGEI | 231 | P10072 | |
| IEGGDGHLFEDEEIK | 791 | Q15063 | |
| KIFVGGIKEDTEEHH | 106 | P09651 | |
| GHYTIGKEIIDLVLD | 106 | P68363 | |
| EIKFHLLDVHGEEIE | 661 | Q7Z4V0 | |
| GHYTIGKEIIDLVLD | 106 | Q9BQE3 | |
| DFHLEIAKKIEIGDG | 286 | Q6IBS0 | |
| KLFTSELGVTEHVEG | 1536 | O75962 | |
| VLGLVHEFKEGKDEL | 76 | Q7Z7D3 | |
| DEELAHLGLGVDVAK | 3006 | O14686 | |
| LLDEEGHIKITDFGL | 191 | Q15349 | |
| LVEGEHVTSDGLKAE | 1046 | Q9NQX4 | |
| EGEILHDAKTLAGNV | 306 | O75113 | |
| VAGVLHLGNIDFEEA | 341 | Q9UM54 | |
| GIDGHLTDNLETEKL | 81 | Q96P71 |